GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sensus Healthcare Inc (FRA:5TX) » Definitions » Float Percentage Of Total Shares Outstanding

Sensus Healthcare (FRA:5TX) Float Percentage Of Total Shares Outstanding : 90.59% (As of Jun. 23, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Sensus Healthcare Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Sensus Healthcare's float shares is 14.85 Mil. Sensus Healthcare's total shares outstanding is 16.39 Mil. Sensus Healthcare's float percentage of total shares outstanding is 90.59%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Sensus Healthcare's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Sensus Healthcare's Institutional Ownership is 10.59%.


Sensus Healthcare Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Sensus Healthcare's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=14.85/16.39
=90.59%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sensus Healthcare (FRA:5TX) Business Description

Industry
Traded in Other Exchanges
Address
851 Broken Sound Parkway, NW, Suite 215, Boca Raton, FL, USA, 33487
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating skin cancers including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.

Sensus Healthcare (FRA:5TX) Headlines

No Headlines